Company Filing History:
Years Active: 2023
Title: **Innovative Contributions of Ludmilla Buzhansky**
Introduction
Ludmilla Buzhansky, an accomplished inventor based in Ariel, IL, has made significant strides in the field of biomedical research. With a focus on synthetic peptides, she has contributed to breakthrough innovations that can enhance healthcare outcomes. Her work primarily revolves around somatostatin receptor ligands, which play a critical role in various therapeutic applications.
Latest Patents
Ludmilla holds one notable patent titled "Synthetic somatostatin receptor ligands." This patent discloses a range of synthetic somatostatin receptor ligands that encompass a peptide moiety along with pharmaceutical compositions and their diverse uses. The patent also covers synthetic somatostatin receptor ligands consisting of a cyclic peptide moiety, along with an active agent moiety that is covalently bonded through a nitrogen atom of a side chain functional group within the cyclic peptide. Furthermore, the patent highlights synthetic somatostatin receptor ligands comprising a nanoparticle active agent moiety, providing innovative avenues for pharmaceutical compositions and applications in medical treatments.
Career Highlights
Ludmilla is associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where she continues to pursue her research interests. Her role at this prestigious organization allows her to explore the therapeutic potential of her inventions, contributing to the company's standing in the medical research sector.
Collaborations
During her career, Ludmilla has collaborated with fellow researchers Genady Kostenich and Mor Oron-Herman. These partnerships reflect her commitment to advancing medical science through collaboration and innovative thinking. Together, they strive to enhance the understanding and applications of her pioneering work on somatostatin receptor ligands.
Conclusion
Ludmilla Buzhansky's contributions to the field of synthetic peptides, particularly through her patent on somatostatin receptor ligands, demonstrate her innovative spirit and commitment to improving healthcare. Her ongoing work at Tel Hashomer Medical Research Infrastructure and Services Ltd., along with her valuable collaborations, positions her as a significant figure in biomedical research, paving the way for future advancements in pharmaceutical sciences.